Assessment of Opioid Analgesia in Sickle Cell

Withdrawn before enrolling · Phase 4

Conditions studied: Sickle Cell Disease

In brief

To develop and validate a non-invasive, in vivo, phenotyping method for CYP2D6 using the non-injurious neuroselective electrical stimulation technique: pain perception threshold/pain tolerance threshold (PPT/PTT) in children and adolescents with sickle cell disease.

Key facts

Study ID
NCT00513864
Run by
Children's National Research Institute
People needed
0
Starts
2006-11-01
Expected to finish
2012-03-01
Last updated by the study team
2014-12-23

Who can join

Age: 7 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.